HC Wainwright & Co. Maintains Buy on Cabaletta Bio, Raises Price Target to $15

HC Wainwright & Co. analyst Douglas Tsao maintains Cabaletta Bio (NASDAQ:CABA) with a Buy and raises the price target from $11 to $15.

HC Wainwright & Co. analyst Douglas Tsao maintains Cabaletta Bio (NASDAQ:CABA) with a Buy and raises the price target from $11 to $15.

Total
0
Shares
Related Posts